Treatments

Paxlovid slashed risk of COVID hospital stay in unvaccinated patients -- Canadian study

Mon, 2023-05-08 17:12 — mike kraft

Paxlovid slashed risk of COVID hospital stay in some patients amid Omicron, study suggests CIDRAP

The antiviral drug Paxlovid was tied to a 96% lower relative risk (RR) of COVID-19 hospitalization among high-risk outpatients who didn't complete a primary vaccination series but didn't benefit those who had received at least two doses amid the SARS-CoV-2 Omicron variant, according to a real-world study published yesterday in Clinical Infectious Diseases.

....

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Analysis

Situation Report

Read more about Paxlovid slashed risk of COVID hospital stay in unvaccinated patients -- Canadian study
Log in or register to post comments

Analysis: Research into treating long COVID is stuck

Mon, 2023-05-08 09:42 — mike kraft

Long COVID Treatment Research Is Stuck in a Frustrating Catch-22 Patients are feeling abandoned, for good reason. Liz Highleyman Slate Magazine

...

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Analysis

Problem

Read more about Analysis: Research into treating long COVID is stuck
Log in or register to post comments

Analysis: Failures in achieving COVID-19 vaccine equity

Fri, 2023-05-05 17:11 — mike kraft

Cascading failures in COVID-19 vaccine equity Ethical analysis should encompass upstream decisions and their downstream consequences Science

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Analysis

Read more about Analysis: Failures in achieving COVID-19 vaccine equity
Log in or register to post comments

Ivermectin suporters lose in Wisconsin Supreme Court

Thu, 2023-05-04 19:24 — mike kraft

Wisconsin Supreme Court won't order ivermectin use for COVID Wisconsin’s conservative-controlled Supreme Court ruled a hospital couldn't be forced to give a deworming drug to a patient with COVID-19, saying a county judge did not cite a legal basis for ordering the facility to administer ivermectin. Ivermectin became popular among conservatives after commentators and even some far-right doctors held up the antiparasitic drug as a miracle cure for the coronavirus and other illnesses. But the Food and Drug Administration hasn't approved it for use in treating COVID-19 and warns that misusing ivermectin can be harmful, even fatal.

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Situation Report

Read more about Ivermectin suporters lose in Wisconsin Supreme Court
Log in or register to post comments

WHO releases strategy paper on COVID disease management and long-term disease prevention

Thu, 2023-05-04 10:55 — mike kraft

From emergency response to long-term COVID-19 disease management: sustaining gains made during the COVID-19 pandemic The updated two-year strategy builds on the objectives of the 2022 SPRP and supports countries as they are working to transition their critical emergency response activities to longer-term sustained COVID-19 disease prevention, control and management.

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Analysis

Read more about WHO releases strategy paper on COVID disease management and long-term disease prevention
Log in or register to post comments

Overview of how the end of the national Covid emergency will affect Americans

Thu, 2023-05-04 10:35 — mike kraft

What the end of the covid public health emergency means for you Here’s how major health policies will be affected when the covid public health emergency ends on on May 11. Washington Post

...

As this long emergency period expires, experts say, the biggest impact for consumers will be the end of free coronavirus tests — both at-home tests and those performed by clinicians and analyzed by commercial labs — with broad implications for people’s ability to get timely covid diagnoses, prevent disease transmission and track the virus.

...

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Analysis

Situation Report

Read more about Overview of how the end of the national Covid emergency will affect Americans
Log in or register to post comments

U.S. FDA approves first RSV vaccine, a long-sought scientific achievement

Wed, 2023-05-03 13:24 — mike kraft

FDA approves first RSV vaccine, a long-sought scientific achievement The FDA has approved the first-ever vaccine for respiratory syncytial virus, or RSV, completing an elusive quest that has been decades in the making. Helen Branswell STAT

... The product, GSK’s Arexvy, was approved for adults ages 60 and older.

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Situation Report

Read more about U.S. FDA approves first RSV vaccine, a long-sought scientific achievement
Log in or register to post comments

After COVID and drug shortages, EU revamps drug laws

Thu, 2023-04-27 10:09 — mike kraft

Explainer: After COVID and drug shortages, EU revamps drug laws The EU is revamping laws governing the 136 billion euro ($148 billion) pharmaceuticals industry aimed at reviving investment and boosting access to affordable drugs at a time when health budgets have been drained by the costs of treating COVID-19. Maggie Fick Reuters

...

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Situation Report

Read more about After COVID and drug shortages, EU revamps drug laws
Log in or register to post comments

Increased physical activity associated with lower risk of severe COVID-19 --study

Thu, 2023-04-27 08:47 — mike kraft

Increased physical activity associated with lower risk of severe COVID-19 CIDRAP

A South Korean study shows a complex relationship between moderate to vigorous physical activity (MVPA) and COVID-19, with a regular exercise habit linked to COVID-19 infection early in the pandemic but also associated with a significantly lower risk of developing severe symptoms. The study was published yesterday in JAMA Network Open.

...

Country / Region Tags:

General Topic Tags: